CASP3 and non-small cell lung carcinoma: In our research, increased mtROS levels and the NOXA/caspase-3 axis-mediated pyroptotic cell death were observed in TP53mutant NSCLC cells after RG7388 treatment (Figs. 2–4 and Fig. 5A and B).